Login / Signup

Gemcitabine plus pembrolizumab after checkpoint blockade failure as a strategy in multiply relapsed Hodgkin lymphoma.

Robert N StuverAriela NoySantosha A VardhanaAndrew D ZelenetzAlison J Moskowitz
Published in: British journal of haematology (2023)
Keyphrases
  • hodgkin lymphoma
  • dna damage
  • cell cycle
  • advanced non small cell lung cancer
  • locally advanced
  • cell proliferation
  • oxidative stress